The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
A complex interplay between Akt, TSC2 and the two mTOR complexes
Open accessAbstract
Akt/PKB (protein kinase B) both regulates and is regulated by the TSC (tuberous sclerosis complex) 1–TSC2 complex. Downstream of PI3K (phosphoinositide 3-kinase), Akt phosphorylates TSC2 directly on multiple sites. Although the molecular mechanism is not well understood, these phosphorylation events relieve the inhibitory effects of the TSC1–TSC2 complex on Rheb and mTORC1 [mTOR (mammalian target of rapamycin) complex] 1, thereby activating mTORC1 in response to growth factors. Through negative-feedback mechanisms, mTORC1 activity inhibits growth factor stimulation of PI3K. This is particularly evident in cells and tumours lacking the TSC1–TSC2 complex, where Akt signalling is severely attenuated due, at least in part, to constitutive activation of mTORC1. An additional level of complexity in the relationship between Akt and the TSC1–TSC2 complex has recently been uncovered. The growth-factor-stimulated kinase activity of mTORC2 [also known as the mTOR–rictor (rapamycin-insensitive companion of mTOR) complex], which normally enhances Akt signalling by phosphorylating its hydrophobic motif (Ser473), was found to be defective in cells lacking the TSC1–TSC2 complex. This effect on mTORC2 can be separated from the inhibitory effects of the TSC1–TSC2 complex on Rheb and mTORC1. The present review discusses our current understanding of the increasingly complex functional interactions between Akt, the TSC1–TSC2 complex and mTOR, which are fundamentally important players in a large variety of human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TSCC is phosphorylated by many kinases, each of which contributes either activating or inhibiting modifications under various environmental conditions, including S6K1, cyclin-dependent kinase 1 (CDK1), AMPK and Akt, which is itself activated by mTORC2 (Huang and Manning, 2009).”
From Signal integration in the (m)TORC1 growth pathway (2018) · cites this paper as Huang and Manning, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Self-citationTOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Mechanism of activation of protein kinase B by insulin and IGF‐1.
Alessi, D. R., Andjelković, M., Caudwell, B., Cron, P. D., MORRICE, N. A., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,014
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,874
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Flagged first, then by citations
1 of the 35 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 501–600 of 723
Antoch, M. P., Wrobel, M. M., Gillard, B. M., Kuropatwinski, K. K., Toshkov, I. A., Gleiberman, A. S., Karasik, E., Moser, M. T., Foster, B. A., Andrianova, E. L., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27550 · Cited by 12
The Role of Pimecrolimus Cream 1% (Elidel®) in Managing Adult Atopic Eczema
Meurer, M., Lübbe, J., Kapp, A., & Schneider, D. M. (2007) · Dermatology · doi:10.1159/000102117 · Cited by 11
Kanno, S., & Hara, A. (2023) · Toxicology in Vitro · doi:10.1016/j.tiv.2023.105698 · Cited by 10
Amosu, M., Jankowski, A. M., McCright, J., Yang, B. E., Fernandez, J. G. D. O., Moore, K. A., Gadde, H. S., Donthi, M., Kaluzienski, M. L., Sriram, V., et al. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2023-0410oc · Cited by 10
Oblongifolin C suppresses lysosomal function independently of TFEB nuclear translocation
Wu, M., Lao, Y., Tan, H., Lu, G. X., Ren, Y., Zheng, Z., Yi, J., Fu, W., Shen, H., & Xu, H. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0167-7 · Cited by 10
Liu, B., Paudel, S., Flowers, W. L., Piedrahita, J. A., & Wang, X. (2023) · Amino Acids · doi:10.1007/s00726-023-03265-6 · Cited by 10
Wang, W., Lv, J., Wang, L., Wang, X., & Ye, L. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.08.024 · Cited by 10
Lymphangioleiomyomatosis: A Case Report and Review of Literature
Rhee, J. A. C., ADIAL, A., Gumpeni, R., & Iftikhar, A. (2019) · Cureus · doi:10.7759/cureus.3938 · Cited by 10
Merlin cooperates with neurofibromin and Spred1 to suppress the Ras–Erk pathway
Cui, Y., Ma, L., Schacke, S., Yin, J. C., Hsueh, Y., Jin, H., & Morrison, H. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa263 · Cited by 10
Conciatori, F., Salvati, E., Ciuffreda, L., Shirasawa, S., Falcone, I., Cognetti, F., Ferretti, G., Zeuli, M., Bufalo, D. D., Bazzichetto, C., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.862806 · Cited by 10
Chemistry and Pharmacology of Rapamycin and Its Derivatives
Abraham, R. T., Gibbons, J. J., & Graziani, E. I. (2010) · The Enzymes · doi:10.1016/s1874-6047(10)27017-8 · Cited by 10
IKBKE inhibits TSC1 to activate the mTOR/S6K pathway for oncogenic transformation
Göktuna, S. İ. (2018) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-1801-57 · Cited by 10
Qiu, J., Yang, T., Long, Y., He, P., Shen, W., Zhang, B., Shi, X., Peng, L., Li, Z., & Zhang, X. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02273-5 · Cited by 9
Wortmannin Reduces Insulin Signaling and Death in Seizure-Prone Pcmt1−/− Mice
MacKay, K. B., Lowenson, J. D., & Clarke, S. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046719 · Cited by 9
Recent insights into the pathophysiology of mTOR pathway dysregulation
Altomare, D. A., & Gitto, S. B. (2015) · Research and Reports in Biology · doi:10.2147/rrb.s57088 · Cited by 9
Saré, R. M., Huang, T., Burlin, T., Loutaev, I., & Smith, C. B. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14311 · Cited by 10
ACSS2-related autophagy has a dual impact on memory
Zhang, H., Xiong, Z., He, Q., & Fan, F. (2019) · Chinese Neurosurgical Journal · doi:10.1186/s41016-019-0162-y · Cited by 10
Ferreri, A., Lang, V., Kaufmann, R., & Buerger, C. (2022) · Cells · doi:10.3390/cells11182847 · Cited by 9
Zhang, T., Wang, L., Pan, Y., He, H., Wang, J., Zhao, T., Ding, T., Wang, Y., Zhao, L., Han, X., et al. (2022) · Theriogenology · doi:10.1016/j.theriogenology.2022.09.017 · Cited by 9
An In Vitro Assay for the Kinase Activity of mTOR Complex 2
Huang, J. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-430-8_6 · Cited by 9
Self-citationYoo, S., Lee, C., Kang, H. C., Lee, H. S., Lee, J. Y., Kim, K. D., Kim, D. J., An, H., & Cho, Y. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23005 · Cited by 9
Hu, Y., Wang, T., Wu, C., Wang, J., Han, X., Zhang, Y., & Zhang, X. (2025) · Advanced Science · doi:10.1002/advs.202500388 · Cited by 8
Innate sensing and cellular metabolism: role in fine tuning antiviral immune responses
Ahmed, D., Daraawi, M. A., & Cassol, E. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiac011 · Cited by 8
Pharmacological effects of mTORC1/C2 inhibitor in a preclinical model of NASH progression
Arora, M., Pavlíková, Z., Kučera, T., Kozlík, P., Šopin, T., Vacı́k, T., Ľupták, M., Duda, M., Slanař, O., & Canová, N. K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115447 · Cited by 9
Giménez‐Xavier, P., Pros, E., Aza, A., Morán, S., Tonda, R., Esteve‐Codina, A., Dabad, M., & Sánchez‐Céspedes, M. (2018) · Oncotarget · doi:10.18632/oncotarget.25862 · Cited by 8
Chronic exposure to methylmercury disrupts ghrelin actions in C57BL/6J mice
Ferrer, B., Prince, L. M., Tinkov, A. A., Santamarı́a, A., Bowman, A. B., & Aschner, M. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111918 · Cited by 8
Maintenance of feeder free anchorage independent cultures of ES and iPS cells by retinol/vitamin A
Bhatia, H., Sharma, R. B., Dawes, J., & Khillan, J. S. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24177 · Cited by 8
da Rosa, P., Dau, A., Cesaro, M. P. D., dos Santos, J., Gasperin, B. G., Duggavathi, R., Bordignon, V., & Gonçalves, P. (2016) · Reproduction in Domestic Animals · doi:10.1111/rda.12745 · Cited by 8
Laviv, Y., Kasper, B. S., & Kasper, E. M. (2017) · Neurosurgical Review · doi:10.1007/s10143-017-0837-9 · Cited by 8
Raymond, A., Javary, J., Breig, O., Neaud, V., & Rosenbaum, J. (2017) · Cell Biochemistry and Function · doi:10.1002/cbf.3274 · Cited by 8
Choi, S., Sadra, A., Kang, J., Ryu, J. R., Kim, J. H., Sun, W., & Huh, S. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.2.172 · Cited by 8
Cheng, T., Zhang, Y., Fan, K., Hu, J.-X., Wang, Q., Wang, Q., Liu, L., Zhang, H., Hou, Y.-P., Li, X., et al. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02676-x · Cited by 7
Signal Transduction Pathways in Ageing
Slack, C., & Tullet, J. M. A. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-2835-0_11 · Cited by 7
Ekizceli, G., Uluer, E. T., & Inan, S. V. (2020) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2020_049 · Cited by 8
iNKT subsets differ in their developmental and functional requirements on Foxo1
Zhang, H., Zhang, Y., Pan, J., Wu, Q., Huang, Y., Bai, S., Tian, C., Zhu, M., Lian, Z., Li, F., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2105950118 · Cited by 7
Chung, N. K. X., Metherall, P., McCormick, J., Simms, R., & Ong, A. C. M. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac037 · Cited by 7
Sun, R., Zhang, Y., Ma, S., Qi, H.-T., Wang, M., Duan, J.-H., Ma, S., Zhu, X., Li, G., & Wang, H. (2015) · Microbiology and Immunology · doi:10.1111/1348-0421.12321 · Cited by 7
Guo, H., Lv, H., Tang, W., Chi, J., Liu, L., Xu, F., Ji, Z., Zhai, X., & Peng, F. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6406-0 · Cited by 7
The balancing act of AKT in T cells
Reneer, M. C., & Martí, F. (2012) · Frontiers in Biology · doi:10.1007/s11515-012-1202-6 · Cited by 7
Oncogenic effects of urotensin-II in cells lacking tuberous sclerosis complex-2
Goldberg, A. A., Joung, K.-B., Mansuri, A., Kang, Y., Echavarría, R., Nikolajev, L., Sun, Y., Yu, J. J., Laporte, S. A., Schwertani, A. G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10748 · Cited by 7
Kabir, E. R., Siam, M. K. S., Kabir, S. M., Khan, A. H., & Rajib, S. A. (2017) · International Conference Computational Systems-Biology and Bioinformatics · doi:10.1145/3156346.3156359 · Cited by 7
Therapeutic Targeting of mTORC2 in mTORopathies
Dentel, B., Escamilla, C. O., & Tsai, P. T. (2019) · Neuron · doi:10.1016/j.neuron.2019.11.026 · Cited by 7
miRNA Regulatory Networks Associated with Peripheral Vascular Diseases
Zalewski, D. P., Ruszel, K. P., Stępniewski, A., Gałkowski, D., Feldo, M., Kocki, J., & Bogucka‐Kocka, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123470 · Cited by 6
Bagh, M. B., Appu, A. P., Sadhukhan, T., Mondal, A., Plavelil, N., Raghavankutty, M., Supran, A. M., Sadhukhan, S., Liu, A., & Mukherjee, A. B. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105641 · Cited by 7
Lysosomes: multifunctional compartments ruled by a complex regulatory network
Martínez‐Fábregas, J., Tamargo‐Azpilicueta, J., & Díaz‐Moreno, I. (2022) · FEBS Open Bio · doi:10.1002/2211-5463.13387 · Cited by 6
Ran, J., Yin, L., Li, J., Tang, Y., Huang, J. H., Ren, P., Zhang, X.-X., Li, S., & Liu, Y. (2022) · Theriogenology · doi:10.1016/j.theriogenology.2022.04.007 · Cited by 6
Self-citationMTORC2 is a physiological hydrophobic motif kinase of S6 Kinase 1
Majeed, S. T., Majeed, R., Malik, A. A., Zargar, M. A., & Andrabi, K. I. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119449 · Cited by 6
The PI3K pathway acting on alternative HIV-1 pre-mRNA splicing
Hillebrand, F., Erkelenz, S., Diehl, N., Widera, M., Noffke, J., Avota, E., Schneider‐Schaulies, S., Dabauvalle, M., & Schaal, H. (2014) · Journal of General Virology · doi:10.1099/vir.0.064618-0 · Cited by 6
High-Resolution Melting Analysis Is a More Effective Approach for Screening TSC Genes Mutations
Tsai, T.-S., Huang, M.-Y., Chang, Y.-T., Wang, C.-Y., Lin, J.-L., Hung, P.-C., Lin, S.-P., Sun, C.-F., Wang, W.-S., Chang, C.-M., et al. (2011) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.0133 · Cited by 6
Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
Kim, W. S. (2011) · Korean Journal of Pediatrics · doi:10.3345/kjp.2011.54.6.241 · Cited by 6
RetractedKarabiyik, C., Vicinanza, M., & Rubinsztein, D. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820538-9.00004-1 · Cited by 6
Chen, X., Adhikary, G., Newland, J. J., Xu, W., Ma, E., Naselsky, W., & Eckert, R. L. (2022) · Molecular Carcinogenesis · doi:10.1002/mc.23446 · Cited by 6
A functional role for Serum Amyloid A in the molecular regulation of autophagy in breast cancer
du Plessis, M., Davis, T., Olivier, D. W., de Villiers, W. J. S., & Engelbrecht, A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1000925 · Cited by 6
Xu, H., Zhao, Y., Zhao, Q., Shi, M., Zhang, Z., Ding, W., & Zhao, Y. X. (2022) · Aging and Disease · doi:10.14336/ad.2022.0408 · Cited by 6
Lipid Modification of Ras Superfamily GTPases
Chenette, E., & Der, C. (2011) · The Enzymes · doi:10.1016/b978-0-12-381339-8.00005-6 · Cited by 5
Unveiling the intricate dance: Obesity and TNBC connection examined
Newport‐Ratiu, P. A., Hussein, K. A., Carter, T., Panjarian, S. B., Jonnalagadda, S. C., & Pandey, M. K. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123082 · Cited by 5
Silwal, A., Reese, B., Patel, B. B., Li, Y., Kolev, M. V., La-Beck, N. M., Karbowniczek, M., & Markiewski, M. M. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2400212 · Cited by 5
López‐Aranda, M. F., Boxx, G. M., Phan, M., Bach, K., Mandanas, R., Herrera, I., Taloma, S. E., Thadani, C., Lu, O., Bui, R., et al. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2022.03.015 · Cited by 5
Cellular signaling impacts upon GABAergic cortical interneuron development
Pai, E. L.-L., Stafford, A. M., & Vogt, D. L. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1138653 · Cited by 5
Ran, Q., Li, A., Yao, B., Xiang, C., Qu, C., Zhang, Y., He, X., & Chen, H. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1523489 · Cited by 5
Lee, Y., Sun, Y., & Glickman, R. D. (2014) · Proteomes · doi:10.3390/proteomes2030399 · Cited by 5
Ramli, I., Posadino, A. M., Giordo, R., Barberis, A., Spissu, Y., Lemoui, R., Setzer, W. N., Sharifi‐Rad, J., & Pintus, G. (2025) · Food Frontiers · doi:10.1002/fft2.70135 · Cited by 4
Shrestha, S., Adib, E., Imani, J., Aguiar, D. J., Lamattina, A. M., Tassew, D., Henske, E. P., Perrella, M. A., Priolo, C., & El‐Chemaly, S. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102580 · Cited by 4
Tu, Y., Pan, B., Wu, X., Hu, X., Li, Q., Zhang, Z., Sheng, P., & Chen, W. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115246 · Cited by 4
Neuronal Autophagy and Prion Proteins
Ragagnin, A., Guillemain, A., Nancy, J., & Bailly, Y. J. R. (2013) · InTech eBooks · doi:10.5772/55646 · Cited by 5
Mechanisms of Resistance to PI3K and AKT Inhibitors
Castel, P., & Scaltriti, M. (2018) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-67932-7_6 · Cited by 5
Effect of physical activity on structural asymmetry of mouse hippocampus
Запара, Т. А., Romashchenko, A. V., Proskura, A. L., & Ratushnyak, A. S. (2019) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj18.454 · Cited by 4
Saré, R. M., Torossian, A., Loutaev, I., & Smith, C. B. (2022) · eNeuro · doi:10.1523/eneuro.0480-21.2022 · Cited by 4
Sun, J. K., Wong, G. C., & Chow, H. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15881 · Cited by 4
Shannon, A. E., Boos, C. E., Searle, B. C., & Hummon, A. B. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00786 · Cited by 4
Impact of Dietary Proteins on Energy Balance, Insulin Sensitivity and Glucose Homeostasis
Chevrier, G., Mitchell, P. L., Beaudoin, M., & Marette, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802167-5.00018-9 · Cited by 5
Ihle, N. T. (2012) · Digital Commons-TMC (Texas Medical Center) · Cited by 4
mTORC1-selective inhibitors rescue cellular phenotypes in TSC iPSC-derived neurons
Buttermore, E. D., Srinivasan, G. R., Jumo, H., Swanson, A. C., O’Kelly, B., Makhortova, N. R., Şahin, M., & Tzannis, S. T. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1595880 · Cited by 3
Ojha, S. K., Kartawy, M., Hamoudi, W., Tripathi, M. K., Aran, A. A., & Amal, H. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03514-6 · Cited by 4
Zou, C., Wang, Y. J., Chen, Q., Shi, J., Wu, X., & Luo, Q. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1745024 · Cited by 3
Sangphech, N., & Palaga, T. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108312 · Cited by 2
The utility of molecular studies on pancreatic cystic lesions: A comprehensive review
Xia, R., Liu, X., Hajdu, C. H., Cao, W., Kaz, J. N., Gonda, T. A., & Simsir, A. (2024) · Human Pathology Reports · doi:10.1016/j.hpr.2024.300741 · Cited by 3
Dual Impact of Iron Deficiency and Antibiotics on Host Metabolism: A Tissue-Level Analysis
Shoff, S., Thomas, S. P., Ji, P., Parenti, M., & Slupsky, C. M. (2025) · Metabolites · doi:10.3390/metabo15080549 · Cited by 3
ZHANG, Y., Wei, C., Xi, J., Tang, Z., & Liang, C. Y. (2015) · Oncology Letters · doi:10.3892/ol.2015.3075 · Cited by 3
RetractedDissection of the autophagic route in oocytes from atretic follicles
Castro-Cruz, A., Echeverría, O. M., Sánchez‐Sánchez, L., Muñoz‐Velasco, I., Juárez‐Chavero, S., Torres‐Ramírez, N., Vázquez‐Nin, G. H., & Escobar, M. L. (2022) · Biology of the Cell · doi:10.1111/boc.202200046 · Cited by 3
López‐Aranda, M. F., Bach, K., Bui, R., Phan, M., Lu, O., Thadani, C., Luchetti, A., Mandanas, R., Herrera, I., López-Ávalos, M. D., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12010203 · Cited by 3
Chen, F., Matsuda, A., Sporn, P. H. S., & Casalino‐Matsuda, S. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094133 · Cited by 3
BCR-ABL negative myeloproliferative neoplasia: a review of involved molecular mechanisms.
Koopmans, S. M., Schouten, H. C., & Marion, A. M. W. V. (2015) · PubMed · doi:10.14670/hh-30.151 · Cited by 3
Adrenomedullin Promotes Rat Trophoblast Stem Cell Differentiation1
Gao, H., Liebenthal, D. A., Yallampalli, U., & Yallampalli, C. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.120378 · Cited by 3
Transcriptional Regulation of De Novo Lipogenesis in Liver
Zhang, D., & Yin, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-25065-6_1 · Cited by 4
Guerrini, V., Bruiners, N., & Gennaro, M. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814603-3.00010-0 · Cited by 3
Metabolic choreography of gene expression: nutrient transactions with the epigenome
Maniyadath, B., Sandra, U. S., & Kolthur‐Seetharam, U. (2020) · Journal of Biosciences · doi:10.1007/s12038-019-9987-y · Cited by 4
Yui, K., Sasaki, H., Imataka, G., & Okanishi, T. (2018) · Global Medicine and Therapeutics · doi:10.15761/gmt.1000101 · Cited by 3
Zhang, Y., Wei, C., Xi, J., Tang, Z., & Liang, C. Y. (2015) · Oncology Letters · doi:10.3892/ol.2015.3620 · Cited by 3
RetractedFarahani, N. I., Wong, K. K. L., Allen, G., Minhas, A., Lin, L. D., Nazir, S., & Julian, L. M. (2025) · Cell Reports Methods · doi:10.1016/j.crmeth.2025.101177 · Cited by 2
Tension to Translation: External to Internal Processes in Muscle Hypertrophy
Greyvenstein, D., Newbold, J. P., & Phillips, S. M. (2025) · Physiology · doi:10.1152/physiol.00034.2025 · Cited by 4
Nautiyal, H., Roy, K. K., & Dwivedi, S. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00574 · Cited by 3
Kobayashi, H., Nishio, M., Umetani, M., Shigetomi, H., Imanaka, S., & Hashimoto, H. (2026) · Reproduction · doi:10.1093/reprod/xaag044 · Cited by 2
Platelet-rich plasma in cartilage repair: biological mechanisms and clinical perspectives
Li, M., Jing, C., Liu, Q., Zhang, Y., & Li, K. (2026) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2026.1785754 · Cited by 4
Babchia, N., DeAraujo, A., Leclère, L., Buteau, B., Martine, L., Gregoire, S., & Brétillon, L. (2014) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201400155 · Cited by 2
Assessment of Response of Kidney Tumors to Rapamycin and Atorvastatin in Tsc1+/− Mice
Shen, M. H., Samsel, P. A., Shen, L. L., Narov, K., Yang, J., & Sampson, J. R. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.07.009 · Cited by 2
The impact of exercise on cardiovascular system: Molecular signaling pathway and cardiac adaptations
Toktarbay, B., Khamitova, Z. K., Zholshybek, N., Jumadilova, D., Rakhmanov, Y., Bekbossynova, M., Gaipov, A., & Salustri, A. (2023) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/jcmk/13825 · Cited by 2
mTOR Signaling and Human Cancer
(2010) · The Enzymes · doi:10.1016/s1874-6047(10)28015-0 · Cited by 2
Metastatic Renal Cancer: What Role for Everolimus?
Belibi, F. A., & Edelstein, C. L. (2010) · Clinical Medicine Reviews in Oncology · doi:10.4137/cmro.s1551 · Cited by 2
The Expanding Role of the mammalian Target of RapamycinComplex 2 (mTORC2) in Cellular Metabolism
Soliman, G. A. (2015) · Archives of Medicine · Cited by 2
Metadata
- Authors
- Huang, J., & Manning, B. D.
- Affiliations
- Harvard University (US)
- Corresponding author
- Manning, Brendan D.
- Venue
- Biochemical Society Transactions
- Publisher
- Portland Press Ltd.
- Published
- 2009-01-20
- Volume
- 37
- Issue
- 1
- Pages
- 217-222
- ISSN
- 0300-5127 (ISSN-L)
- 1470-8752
- PMC
- PMC2778026
- OpenAlex
- W2065322400
- Cited by
- 724
- References
- 35
- Citations by year
- 2026: 17 · 2025: 18 · 2024: 21 · 2023: 22 · 2022: 31 · 2021: 31 · 2020: 37 · 2019: 40 · 2018: 49 · 2017: 40 · 2016: 38 · 2015: 53 · 2014: 60 · 2013: 51 · 2012: 67
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biochemical Society Transactions (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA122617, P01CA120964)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- Akt, TSC1/TSC2 complex, tuberous sclerosis complex, mTORC1, mTORC2, PI3K signaling, Rheb, Akt phosphorylation, negative feedback regulation, growth factor signaling, tumor growth
- MeSH terms
- Tuberous Sclerosis Complex 2 Protein, Animals, Humans, Protein Kinases, Transcription Factors, Phosphatidylinositol 3-Kinases, Feedback, Physiological, Tumor Suppressor Proteins, Proto-Oncogene Proteins c-akt, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review